Cryo-EM structures of human fucosidase FucA1 reveal insight into substrate recognition and catalysis

Zachary Armstrong,Richard W Meek,Liang Wu,James N Blaza,Gideon J Davies,Richard W. Meek,James N. Blaza,Gideon J. Davies

DOI: https://doi.org/10.1016/j.str.2022.07.001

IF: 5.871

2022-10-06

Structure

Abstract:Enzymatic hydrolysis of α-L-fucose from fucosylated glycoconjugates is consequential in bacterial infections and the neurodegenerative lysosomal storage disorder fucosidosis. Understanding human α-L-fucosidase catalysis, in an effort toward drug design, has been hindered by the absence of three-dimensional structural data for any animal fucosidase. Here, we have used cryoelectron microscopy (cryo-EM) to determine the structure of human lysosomal α-L-fucosidase (FucA1) in both an unliganded state and in complex with the inhibitor deoxyfuconojirimycin. These structures, determined at 2.49 Å resolution, reveal the homotetrameric structure of FucA1, the architecture of the catalytic center, and the location of both natural population variations and disease-causing mutations. Furthermore, this work has conclusively identified the hitherto contentious identity of the catalytic acid/base as aspartate-276, representing a shift from both the canonical glutamate acid/base residue and a previously proposed glutamate residue. These findings have furthered our understanding of how FucA1 functions in both health and disease.

cell biology,biochemistry & molecular biology,biophysics